Burden of asthma with elevated blood eosinophil levels

BACKGROUND: Asthma is a common chronic condition with an economic burden of almost $56 billion annually in the US. Biologic markers like blood eosinophils, that help predict the risk of exacerbation could help guide more optimal treatment plans and reduce cost. The purpose of this study was to deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Casciano, Julian, Krishnan, Jerry A., Small, Mary Buatti, Buck, Philip O., Gopalan, Gokul, Li, Chenghui, Kemp, Robert, Dotiwala, Zenobia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944449/
https://www.ncbi.nlm.nih.gov/pubmed/27412347
http://dx.doi.org/10.1186/s12890-016-0263-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944449/
https://www.ncbi.nlm.nih.gov/pubmed/27412347
http://dx.doi.org/10.1186/s12890-016-0263-8

Ejemplares similares